Editor

Symphera Secures €2.4M to Revolutionize Laparoscopic Surgery Tool-Switching

In a significant leap for minimally invasive surgical technology, Munich-based medtech innovator Symphera has successfully raised €2.4 million in a Seed financing round. This funding will propel the company’s groundbreaking work in automating tool-switching during laparoscopic procedures, effectively rendering manual instrument changes obsolete. With a simple push of a button, surgeons can seamlessly transition between…

Read More

AttoTude Secures $29 Million in Series A Funding to Transform High-Speed Networking for AI and Data Centers

AttoTude, a pioneering company in high-speed interconnect technology for artificial intelligence and hyperscale data center applications, has announced the successful closure of its $29 million Series A funding round. This latest investment follows an $11 million Seed Round concluded earlier this year. The Series A round saw contributions from notable investors, including Sutter Hill Ventures,…

Read More

Cellino Secures $25 Million Grant from ARPA-H to Revolutionize Biomanufacturing for Personalized Regenerative Medicine

In a landmark development for the field of regenerative medicine, Cellino Biotech, Inc. has been awarded up to $25 million in funding from the Advanced Research Projects Agency for Health (ARPA-H), a division within the U.S. Department of Health and Human Services. This grant will significantly advance Cellino’s NEBULA, a cutting-edge biomanufacturing technology designed to…

Read More

Illuma Labs Secures $9 Million in Series A Funding to Enhance Voice Authentication and Combat Fraud

Illuma Labs, a pioneering force in voice authentication technology for banking institutions, has successfully closed a $9 million Series A funding round. The investment, led by LiveOak Ventures and supported by Forefront Venture Partners, Curql Fund, UsNet, Capital Factory, Connexus, and TDECU, will drive the company’s efforts to develop cutting-edge solutions to tackle fraud, voice…

Read More

Radiant Biotherapeutics Secures $35 Million in Series A Funding to Propel Multabody™ Platform

Radiant Biotherapeutics, a cutting-edge biotechnology firm specializing in advanced antibody therapies, has announced the successful closure of a $35 million Series A financing round. This significant investment, spearheaded by the Bill & Melinda Gates Foundation and Amplitude Ventures, aims to further develop Radiant’s innovative Multabody™ platform, which is poised to revolutionize therapeutic approaches across various…

Read More

Qualifyze Secures $54 Million in Series B Funding to Revolutionize Supplier Risk Management in Life Sciences

In a significant boost for the Life Sciences industry, Qualifyze has announced a landmark $54 million Series B funding round. This investment, led by global software investment firm Insight Partners, alongside existing backers HV Capital, HarbourVest Partners, H14, and Cherry Ventures, is set to propel Qualifyze into a new phase of growth and innovation. With…

Read More

Quantum Source Secures $50M Series A Round to Revolutionize Quantum Computing

In a landmark development for the quantum computing industry, Quantum Source has successfully closed a $50 million Series A funding round. The investment, spearheaded by Eclipse, was also supported by prominent investors including Standard Investments, Level VC, Canon Equity, as well as existing backers Pitango First, Grove Ventures, 10D, and Dell Technologies Capital. This latest…

Read More

LifeSpan Vision Ventures Invests in Remedium Bio to Advance Pioneering Gene Therapy Platform

LifeSpan Vision Ventures has made a significant investment in Remedium Bio, a biotechnology firm renowned for its groundbreaking gene therapy platform, Prometheus™. This latest funding is set to propel Remedium Bio’s innovative approach to gene therapy into new realms of clinical research and application. Remedium Bio is at the forefront of biotechnology with its Prometheus™…

Read More

webAI Secures $60 Million Funding to Transform AI Accessibility and Efficiency

webAI, an Austin-based leader in AI innovation, has announced a significant milestone in its mission to revolutionize artificial intelligence with the completion of a $60 million Series A funding round. This pivotal investment underscores the growing momentum behind webAI’s vision to democratize AI and enhance its accessibility for enterprises worldwide. The fresh capital injection brings…

Read More